Synergistic effects of trastuzumab and gambogic acid on MDA-MB-453 breast cancer cell line
Trastuzumab is one of the most commonly used monoclonal antibodies in the treatment of breast cancer. It is effective because it binds to the HER2 receptor and inhibits the signaling pathways for proliferation and metastasis. However, intrinsic or acquired resistance resulting from the various signa...
Guardat en:
| Autors principals: | , |
|---|---|
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Polskie Towarzystwo Farmaceutyczne
2023-07-01
|
| Col·lecció: | Acta Poloniae Pharmaceutica |
| Matèries: | |
| Accés en línia: | https://www.ptfarm.pl/download/?file=File%2FActa_Poloniae%2F2023%2F3%2F409.pdf |
| Etiquetes: |
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|